Form D · Biotechnology
Santa Ana Bio, Inc.
Alameda, CA · CIK 0001864492
Offering snapshot reported Jun 17, 2024 · SEC filing
- Reported sold
- $20M Offering amount: $125M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 16, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2024 | Initial | $19,999,998 | No comparison | 10 | SEC filing |
| Feb 28, 2023 | Initial | $35,313,642 | No comparison | 5 | SEC filing |
| Jun 1, 2021 | Initial | $8,024,658 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-516165
Source: Form D, filed Jun 17, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marcelo Bigalo | Director |
| Christine Borowski | Director |
| Brendan Bulik Sullivan | Director |
| Jerel Davis | Director |
| Mittie Doyle | Director |
| Peter Emtage | Director, Executive |
| Shinichiro Fuse | Director |
| Thomas Woiwode | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1105 Atlantic Ave. Suite 104
Alameda, CA, 94501
Alameda, CA, 94501